REG - Abingdon Health PLC - Award of Options under LTIP
Yesterday 12:15
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250502:nRSB2758Ha&default-theme=true
RNS Number : 2758H Abingdon Health PLC 02 May 2025
Abingdon Health plc
("Abingdon Health", the "Group" or the "Company")
Award of Options under LTIP
York, U.K. 2 May 2025: Abingdon Health plc (AIM: ABDX), a leading
international developer, manufacturer and distributor of high quality and
effective rapid tests, announces that, under the terms of the existing Long
Term Incentive Plan established in December 2022 ("LTIP" or the
"Plan"), the Company has awarded share options ("Options") over a total of
4,092,000 ordinary shares of 0.025 pence each ("Ordinary Shares") to
certain directors and senior management, in order to incentivise and encourage
retention in a manner that aligns with the interests of the Company's
shareholders.
The Options are nil cost and will vest over the period to 30 June 2027.
Vesting of the Options is conditional upon the business achieving certain
challenging total shareholder return criteria.
The following directors and members of the senior management team (each a
person discharging managerial responsibilities ("PDMR")) have been awarded
options:
PDMR Role No. of new Options awarded under the LTIP No. of existing Options under the LTIP Total number of Options under the LTIP
Chris Hand Executive Chairman 946,000 712,057 1,658,057
Chris Yates Chief Commercial Officer / President, Abingdon Health USA Inc 946,000 2,136,173 3,082,173
Tom Hayes Chief Financial Officer 660,000 - 660,000
Mark Jones Chief Operating Officer 500,000 1,001,376 1,501,376
Nina Garrett Chief Technical Officer 420,000 852,156 1,272,156
Candice Vendettuoli Head of QARA 320,000 469,200 789,200
Natalie Thrush Head of HR / Site Lead 300,000 158,807 458,807
Enquiries:
Abingdon Health plc www.abingdonhealth.com/investors/ (http://www.abingdonhealth.com/investors/)
Chris Hand, Executive Chairman Via Walbrook PR
Tom Hayes, CFO
Zeus (Sole Broker and Nominated Adviser) Tel: +44 (0)20 3829 5000
Antonio Bossi / Alexandra Campbell-Harris (Corporate Finance)
Fraser Marshall (Corporate Broking)
Walbrook PR (Media & Investor Relations) Tel: +44 (0)20 7933 8780 or abingdon@walbrookpr.com
(mailto:abingdon@walbrookpr.com)
Paul McManus / Alice Woodings Mob: +44 (0)7980 541 893 / +44 (0)7407 804 654
About Abingdon Health plc
Abingdon Health is a leading med-tech contract service provider offering its
services to an international customer base.
The Group's CDMO division (https://www.abingdonhealth.com/services/) offers
lateral flow product development, regulatory support, technology transfer and
manufacturing services for customers looking to develop new assays or transfer
existing laboratory-based assays to a lateral flow format. Abingdon Health's
CDMO division has the internal capabilities to take lateral flow projects, in
areas such as infectious disease and clinical testing, including companion
diagnostics, animal health and environmental testing, from initial concept
through to routine and large-scale manufacturing; from "idea to commercial
success".
Abingdon's regulatory services companies, Compliance Solutions (Life Sciences)
(https://cslifesciences.com) and IVDeology provide a broad range of regulatory
services to the in vitro diagnostic and wider medical device industry, to
support customers in bringing products to market across a range of territories
including the USA, EU and the UK. Our consultancy services range from design,
implementation and maintenance of quality management systems, preparation of
technical files for regulatory approvals, part-time and interim management
support, auditing both internally (e.g. Quality Management Systems) and
externally (e.g. critical suppliers), management reviews and presentations,
training and mentoring.
Abingdon Simply Test(TM) range of self-tests are marketed via an e-commerce
platform that offers a range of self-tests to empowers consumers to manage
their own health and wellbeing. The Abingdon Simply Test
(http://www.abingdonsimplytest.com) (TM) e-commerce site offers consumers a
range of information to support them in making informed decisions on the tests
available. In addition, the site provides Abingdon's contract services
customers with a potential route to market for self-tests. The Abingdon Simply
Test range and other selected self-test products, such as the saliva pregnancy
test, Salistick (https://www.salignostics.com/salistick/) (TM
(https://www.salignostics.com/salistick/) ), is also sold through
international distributors and through other channels in the UK and Ireland,
such as pharmacy chains.
Founded in 2008, Abingdon Health is headquartered in York, England with
CDMO facilities in both York, UK and Madison, Wisconsin, USA. For more
information visit: www.abingdonhealth.com (http://www.abingdonhealth.com/)
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Chris Hand
2 Reason for the notification
a) Position/Status: Executive Chairman
b) Initial Notification/Amendment: Initial Notification
3 Details of the issuer, emission allowance market participation, auction
platform, auctioneer or auction monitor
a) Name: Abingdon Health plc
b) LEI: 213800XFI4WV3FBILO20
4. Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a) Description of the financial instrument: Ordinary Shares of 0.025 pence each
Identification code: GB00BLF79J41
b) Nature of the transaction: Award of LTIP Options
c) Price(s) and volume(s): Price(s) Volume(s)
Nil 946,000
d) Aggregated volume: See above
Price:
e) Date of the Transaction: 2 May 2025
f) Place of the Transaction: Outside a trading venue
4.
Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a)
Description of the financial instrument:
Identification code:
Ordinary Shares of 0.025 pence each
GB00BLF79J41
b)
Nature of the transaction:
Award of LTIP Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil
946,000
d)
Aggregated volume:
Price:
See above
e)
Date of the Transaction:
2 May 2025
f)
Place of the Transaction:
Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Chris Yates
2 Reason for the notification
a) Position/Status: Chief Commercial Officer / President, Abingdon Health USA Inc
b) Initial Notification/Amendment: Initial Notification
3 Details of the issuer, emission allowance market participation, auction
platform, auctioneer or auction monitor
a) Name: Abingdon Health plc
b) LEI: 213800XFI4WV3FBILO20
4. Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a) Description of the financial instrument: Ordinary Shares of 0.025 pence each
Identification code: GB00BLF79J41
b) Nature of the transaction: Award of LTIP Options
c) Price(s) and volume(s): Price(s) Volume(s)
Nil 946,000
d) Aggregated volume: See above
Price:
e) Date of the Transaction: 2 May 2025
f) Place of the Transaction: Outside a trading venue
4.
Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a)
Description of the financial instrument:
Identification code:
Ordinary Shares of 0.025 pence each
GB00BLF79J41
b)
Nature of the transaction:
Award of LTIP Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil
946,000
d)
Aggregated volume:
Price:
See above
e)
Date of the Transaction:
2 May 2025
f)
Place of the Transaction:
Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Tom Hayes
2 Reason for the notification
a) Position/Status: Chief Financial Officer
b) Initial Notification/Amendment: Initial Notification
3 Details of the issuer, emission allowance market participation, auction
platform, auctioneer or auction monitor
a) Name: Abingdon Health plc
b) LEI: 213800XFI4WV3FBILO20
4. Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a) Description of the financial instrument: Ordinary Shares of 0.025 pence each
Identification code: GB00BLF79J41
b) Nature of the transaction: Award of LTIP Options
c) Price(s) and volume(s): Price(s) Volume(s)
Nil 660,000
d) Aggregated volume: See above
Price:
e) Date of the Transaction: 2 May 2025
f) Place of the Transaction: Outside a trading venue
4.
Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a)
Description of the financial instrument:
Identification code:
Ordinary Shares of 0.025 pence each
GB00BLF79J41
b)
Nature of the transaction:
Award of LTIP Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil
660,000
d)
Aggregated volume:
Price:
See above
e)
Date of the Transaction:
2 May 2025
f)
Place of the Transaction:
Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Mark Jones
2 Reason for the notification
a) Position/Status: Chief Operating Officer
b) Initial Notification/Amendment: Initial Notification
3 Details of the issuer, emission allowance market participation, auction
platform, auctioneer or auction monitor
a) Name: Abingdon Health plc
b) LEI: 213800XFI4WV3FBILO20
4. Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a) Description of the financial instrument: Ordinary Shares of 0.025 pence each
Identification code: GB00BLF79J41
b) Nature of the transaction: Award of LTIP Options
c) Price(s) and volume(s): Price(s) Volume(s)
Nil 500,000
d) Aggregated volume: See above
Price:
e) Date of the Transaction: 2 May 2025
f) Place of the Transaction: Outside a trading venue
4.
Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a)
Description of the financial instrument:
Identification code:
Ordinary Shares of 0.025 pence each
GB00BLF79J41
b)
Nature of the transaction:
Award of LTIP Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil
500,000
d)
Aggregated volume:
Price:
See above
e)
Date of the Transaction:
2 May 2025
f)
Place of the Transaction:
Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Nina Garrett
2 Reason for the notification
a) Position/Status: Chief Technical Officer
b) Initial Notification/Amendment: Initial Notification
3 Details of the issuer, emission allowance market participation, auction
platform, auctioneer or auction monitor
a) Name: Abingdon Health plc
b) LEI: 213800XFI4WV3FBILO20
4. Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a) Description of the financial instrument: Ordinary Shares of 0.025 pence each
Identification code: GB00BLF79J41
b) Nature of the transaction: Award of LTIP Options
c) Price(s) and volume(s): Price(s) Volume(s)
Nil 420,000
d) Aggregated volume: See above
Price:
e) Date of the Transaction: 2 May 2025
f) Place of the Transaction: Outside a trading venue
4.
Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a)
Description of the financial instrument:
Identification code:
Ordinary Shares of 0.025 pence each
GB00BLF79J41
b)
Nature of the transaction:
Award of LTIP Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil
420,000
d)
Aggregated volume:
Price:
See above
e)
Date of the Transaction:
2 May 2025
f)
Place of the Transaction:
Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Candice Vendettuoli
2 Reason for the notification
a) Position/Status: Head of QARA
b) Initial Notification/Amendment: Initial Notification
3 Details of the issuer, emission allowance market participation, auction
platform, auctioneer or auction monitor
a) Name: Abingdon Health plc
b) LEI: 213800XFI4WV3FBILO20
4. Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a) Description of the financial instrument: Ordinary Shares of 0.025 pence each
Identification code: GB00BLF79J41
b) Nature of the transaction: Award of LTIP Options
c) Price(s) and volume(s): Price(s) Volume(s)
Nil 320,000
d) Aggregated volume: See above
Price:
e) Date of the Transaction: 2 May 2025
f) Place of the Transaction: Outside a trading venue
4.
Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a)
Description of the financial instrument:
Identification code:
Ordinary Shares of 0.025 pence each
GB00BLF79J41
b)
Nature of the transaction:
Award of LTIP Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil
320,000
d)
Aggregated volume:
Price:
See above
e)
Date of the Transaction:
2 May 2025
f)
Place of the Transaction:
Outside a trading venue
1 Details of the person discharging managerial responsibilities/person closely
associated
a) Name: Natalie Thrush
2 Reason for the notification
a) Position/Status: Head of HR / Site Lead
b) Initial Notification/Amendment: Initial Notification
3 Details of the issuer, emission allowance market participation, auction
platform, auctioneer or auction monitor
a) Name: Abingdon Health plc
b) LEI: 213800XFI4WV3FBILO20
4. Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a) Description of the financial instrument: Ordinary Shares of 0.025 pence each
Identification code: GB00BLF79J41
b) Nature of the transaction: Award of LTIP Options
c) Price(s) and volume(s): Price(s) Volume(s)
Nil 300,000
d) Aggregated volume: See above
Price:
e) Date of the Transaction: 2 May 2025
f) Place of the Transaction: Outside a trading venue
4.
Details of transaction(s); section to be repeated for (i) each type of
instrument; (ii) each type of transaction; (iii) each date; and (iv) each
place where transactions have been conducted.
a)
Description of the financial instrument:
Identification code:
Ordinary Shares of 0.025 pence each
GB00BLF79J41
b)
Nature of the transaction:
Award of LTIP Options
c)
Price(s) and volume(s):
Price(s)
Volume(s)
Nil
300,000
d)
Aggregated volume:
Price:
See above
e)
Date of the Transaction:
2 May 2025
f)
Place of the Transaction:
Outside a trading venue
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHBGGDULUGDGUDRecent news on Abingdon Health
See all newsREG - Abingdon Health PLC - Award of Options under LTIP
AnnouncementREG - Abingdon Health PLC - Half-year Report
AnnouncementREG - Abingdon Health PLC - Directorate Changes
AnnouncementREG - Abingdon Health PLC - Notice of Results
AnnouncementREG - Abingdon Health PLC - Salistick™ to be launched in Germany
Announcement